Arlene Chapman to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Arlene Chapman has written about TOR Serine-Threonine Kinases.
Connection Strength
0.021
-
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol. 2010 Jul; 5(7):1312-29.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.